Delivery Order SPE2DB24D1021-SPE2DB25FFAPQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,855.22 on September 4, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- The Defense Logistics Agency awarded a $85,522.33 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRIUMEQ 600-50-300 MG tablets (30-count units) with a ceiling value of $78,899.37. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $9,867.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $53,093.78 for 30-unit supplies of Triumeq 600-50-300 mg tablets. This firm fixed-price contract was issued by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $6,519.84 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger federal contract vehicle. This award falls under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a $17,645.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of TRIUMEQ 600-50-300 mg. The contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, was not set aside for small businesses or other designated groups and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,519.84 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 13, 2025, with a completion date of August 14, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an expansive $999.99 billion pharmaceutical supply agreement running through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, for the provision of TRIUMEQ 600-50-300 MG tablets. The $15,507.76 contract has an ultimate completion date of November 18, 2021. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a potential ceiling...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAPQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Triumeq 600-50-300 mg tablets (30-count units) with a ceiling value of $35,571.24. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by September 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive capability to meet federal pharmaceutical procurement requirements. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent delivery of brand-name and generic pharmaceuticals across multiple therapeutic domains to meet ongoing defense medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.6k | 9/11/25 |